Multiple Biologics for Multiple T2 Diseases: A Pharmacoepidemiological Algorithm for Sorting Out Patients by Indication.

Jérémy CharriotVincent DescampsRoger JankowskiMilka MaravicArnaud Bourdin

Published in: Journal of asthma and allergy (2023)

The algorithm was able to identify patients with T2 diseases under Bx/TSD treatments. This tool may help to follow the evolution of prescription patterns in the future.

Keyphrases

end stage renal disease
machine learning
ejection fraction
deep learning
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes